CRISPR Screening Identifies CDK12 as a Conservative Vulnerability of Prostate Cancer

By
Justin.choi
-
0
36
The authors performed a kinome-scale CRISPR/Cas9 screen and identified cyclin-dependent kinase 12 (CDK12) as being conservatively required for PCa cell survival.
[Cell Death & Disease]

Sorry, but the selected Zotpress account can't be found.

Full Article